Chi-X adds global blue-chip US listed companies
Chi-X Australia, together with Deutsche Bank, has unveiled the next tranche of US listed companies that would be available to investors through its investment vehicle, Transferable Custody Receipts (TraCRs).
The new additions would include the following companies: Amazon, Warren Buffet’s conglomerate Berkshire Hathaway, Pfizer, Merck and Johnson & Johnson, making it a total of 15 global blue-chip US listed companies available to local investors on Chi-X Australia.
TraCRS trade in Australian dollars, on a local exchange and during Australian trading hours and provided investors with ownership of the underlying share which could be bought and sold like any domestic security.
“TraCRs have removed many of the traditional barriers to entry for those looking to access US equities and allow Australian investors to easily and cheaply trade well known, blue-chip brands on an Australian exchange,” Deutsche Bank’s head of depositary receipts Australia and New Zealand, Chris Bagley, said.
“Our partnership with Chi-X means we can be nimble in providing Australian investors with ongoing exposure to attractive global growth sectors.”
TraCRs are issued by Deutsche Access Investments Limited, a member of the Deutsche Bank group, and are exclusively traded on the Chi-X Australia exchange, accessible through a range of domestic brokers including CommSec, OpenMarkets, Morgans, Shaw and Partners and State One, the firm said.
AUTHOR
Oksana Patron
Recommended for you
Some 42 per cent of CEOs say they are actively reinventing their business to stay relevant in the next decade, with consumer services the most common choice for asset and wealth managers.
Former Ophir Asset Management chief executive, George Chirakis, has joined private equity manager Scarcity Partners, while the asset manager has appointed a replacement from Macquarie.
Australian Unity has appointed a fund manager for its Healthcare Property Trust, joining from Centuria Healthcare, as it restructures the product with a series of senior appointments.
Financial advisers nervous about the liquidity of private markets funds for their retail clients are the target of fund managers launching semi-liquid products which offer greater flexibility and redemptions.
